Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy and Safety Comparison of Insulin Detemir vs. NPH Insulin in Children and Adolescents Diagnosed With Type 1 Diabetes

NCT00435019 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00435019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00435019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy and Safety Comparison of Insulin Detemir vs. NPH Insulin in Children and Adolescents Diagnosed With Type 1 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
September 30, 2008
Enrollment
348 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1